ESCI期刊Ocular Oncology and Pathology 2024/2025影响因子:0.998 (OCUL ONCOL PATHOL) (2296-4681). (OPHTHALMOLOGY)(眼科学)Emerging S

显示全部楼层 · 发表于 2025-3-25 12:27:00

Submitted on: 02 February 2001. Revised on: 02 March 2001. Accepted on: 13 March 2001. Ocular Oncology and Pathology

显示全部楼层 · 发表于 2025-3-25 16:58:17

Submitted on: 20 March 2016. Revised on: 08 April 2016. Accepted on: 19 April 2016. Ocular Oncology and Pathology---KARGER

显示全部楼层 · 发表于 2025-3-25 21:29:35

Submitted on: 21 September 2010. Revised on: 02 November 2010. Accepted on: 19 November 2010. Ocular Oncology and Pathology

显示全部楼层 · 发表于 2025-3-26 01:34:18

Submitted on: 08 September 2023. Revised on: 03 October 2023. Accepted on: 26 October 2023. Ocular Oncology and Pathology

显示全部楼层 · 发表于 2025-3-26 07:01:23

Submitted on: 11 June 2013. Revised on: 13 July 2013. Accepted on: 01 August 2013. Ocular Oncology and Pathology---KARGER

显示全部楼层 · 发表于 2025-3-26 11:59:25

Submitted on: 06 February 1998. Revised on: 24 February 1998. Accepted on: 03 March 1998. Ocular Oncology and Pathology

显示全部楼层 · 发表于 2025-3-26 14:17:16

显示全部楼层 · 发表于 2025-3-26 16:53:11

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-1 08:08
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved